Revolution drug shows promise in early pancreatic cancer
BioPharma Dive
The findings build on data suggesting Revolution s therapy could upend treatment for a notoriously tough-to-treat tumor and generate billions in sales.
pharminent
April 22, 2026 (Last updated: April 23, 2026)
BioPharma Dive
The findings build on data suggesting Revolution s therapy could upend treatment for a notoriously tough-to-treat tumor and generate billions in sales.
